Institutional Manager · CIK 0001937964
Artia Global Partners LP
MIAMI, FL · File #028-23071
Latest AUM
$705.8M
Positions
55
Top-10 Concentration
71.9%
Filings
10
Portfolio Value Over Time
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| EXITED | VERONA PHARMA PLC | 925050106 | -379,004 | -$40.4M | $0 |
| REDUCE | ABIVAX SA | AAVXF | -215,553 | -$29.1M | +$11.3M |
| REDUCE | SOLENO THERAPEUTICS INC | SLNO | -622,176 | -$28.8M | -$14.3M |
| EXITED | MERUS N V | N5749R100 | -296,750 | -$27.9M | $0 |
| REDUCE | PROSHARES TR II | 74347W601 | -437,372 | -$24.3M | +$5.1M |
| ADD | ELI LILLY & CO | LLY | +21,800 | +$23.4M | +$8.9M |
| EXITED | VERTEX PHARMACEUTICALS INC | 92532F100 | -55,100 | -$21.6M | $0 |
| ADD | VIKING THERAPEUTICS INC | VKTX | +573,186 | +$20.2M | +$1.3M |
| EXITED | BOSTON SCIENTIFIC CORP | 101137107 | -183,200 | -$17.9M | $0 |
| NEW | CIDARA THERAPEUTICS INC | 171757206 | +70,824 | +$15.6M | $0 |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 202555 pos · $705.8M
- 13F HOLDINGS REPORT (Amended)Q/E Sep 202551 pos · $630.9M
- 13F HOLDINGS REPORTQ/E Sep 202551 pos · $630.9M
- 13F HOLDINGS REPORTQ/E Jun 202537 pos · $415.6M
- 13F HOLDINGS REPORTQ/E Mar 202538 pos · $395.1M
- 13F HOLDINGS REPORTQ/E Dec 202437 pos · $279.8M
- 13F HOLDINGS REPORTQ/E Sep 202445 pos · $366.9M
- 13F HOLDINGS REPORTQ/E Jun 202446 pos · $517.3M
- 13F HOLDINGS REPORTQ/E Mar 202449 pos · $497.5M
- 13F HOLDINGS REPORTQ/E Dec 202327 pos · $240.6M
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | INSMED INC | INSM | 682,212 | $118.7M | 16.88% |
| 2 | ABIVAX SA | AAVXF | 600,747 | $81.0M | 11.52% |
| 3 | INSMED INC | INSM | 420,000 | $73.1M | 10.39% |
| 4 | ARGENX SE | ARGX | 64,699 | $54.4M | 7.73% |
| 5 | ELI LILLY & CO | LLY | 50,500 | $54.3M | 7.71% |
| 6 | VIKING THERAPEUTICS INC | VKTX | 719,365 | $25.3M | 3.60% |
| 7 | TREVI THERAPEUTICS INC | TRVI | 2,013,602 | $25.2M | 3.58% |
| 8 | SOLENO THERAPEUTICS INC | SLNO | 533,698 | $24.7M | 3.51% |
| 9 | PROSHARES TR II | 74347W601 | 442,119 | $24.5M | 3.49% |
| 10 | UNIQURE NV | QURE | 1,023,539 | $24.5M | 3.48% |
| 11 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 503,936 | $17.7M | 2.51% |
| 12 | ASTRAZENECA PLC | AZN | 190,752 | $17.5M | 2.49% |
| 13 | CIDARA THERAPEUTICS INC | 171757206 | 70,824 | $15.6M | 2.22% |
| 14 | EYEPOINT PHARMACEUTICALS INC | EYPT | 767,098 | $14.0M | 1.99% |
| 15 | IONIS PHARMACEUTICALS INC | IONS | 144,376 | $11.4M | 1.62% |
| 16 | DIANTHUS THERAPEUTICS INC | DNTH | 205,090 | $8.5M | 1.20% |
| 17 | REVOLUTION MEDICINES INC | RVMDW | 104,190 | $8.3M | 1.18% |
| 18 | QUEST DIAGNOSTICS INC | DGX | 40,817 | $7.1M | 1.01% |
| 19 | ALNYLAM PHARMACEUTICALS INC | ALNY | 17,400 | $6.9M | 0.98% |
| 20 | VENTYX BIOSCIENCES INC | 92332V107 | 695,982 | $6.3M | 0.89% |